Pro-Dex Inc New (PDEX) Stock: Buy, Sell, or Hold?
PDEX - Pro-Dex Inc New
$64.07
-1.29 (-1.97%)
▼
5d:
-10.73%
30d:
+2.38%
90d:
+3.62%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 29, 2026
25d
Get Alerted When PDEX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PDEX is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PDEX is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PDEX is currently trading at $64.07, which is considered slightly low relative to its 30-day fair value range of $62.63 to $71.41.
Technical Outlook: Technically, PDEX is in a uptrend. The price is currently testing key support at $63.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PDEX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $74.00 (+15.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PDEX is in a uptrend. The price is currently testing key support at $63.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PDEX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $74.00 (+15.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$62.63 -
$71.41
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($74.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.63 -
$71.41
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$63.74
Resistance Level
$74.20
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.42
Wall Street Target
$74.00
(+15.5%)
Revenue Growth (YoY)
16.6%
Earnings Growth (YoY)
143.4%
Profit Margin
17.6%
Share & Embed Analysis
Last updated: October 03, 2026 12:09 PM ET
Data refreshes hourly during market hours. Next update: 1:09 PM
Data refreshes hourly during market hours. Next update: 1:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PDEX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 53 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 35 SELL |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 67 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 61 BUY |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$206 | 65 BUY |
